Figure 3:
Correlation between respondents’ level of comfort (measured on a 10-point scale) with prescribing cannabinoids for chronic noncancer pain and the prevalence of cannabinoid prescription for that indication.
Correlation between respondents’ level of comfort (measured on a 10-point scale) with prescribing cannabinoids for chronic noncancer pain and the prevalence of cannabinoid prescription for that indication.